ENLT is trading 6.9% down today at $82.90 after UBS lowered its price target to $115 from $123, citing higher expected operating expenses as the company scales its capacity.
- UBS maintained its Buy rating but reduced EBITDA estimates for 2026 to 2028, reflecting concerns over rising costs pressuring future profitability.
- The stock's decline comes despite a strong year-to-date performance, as investors pivot focus toward long-term margin outlooks.